MedTrace Logo

Saccharomyces Boulardii in Diarrhea Dominant Irritable Bowel Syndrome

NCT00543478 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2007-10-15

No results posted yet for this study

Summary

Probiotics are friendly bacteria normally present in food products like yogurt whereas irritable bowel syndrome is a longstanding functional disorder characterized by abdominal pain and altered bowel habits either diarrhea or constipation dominant without a definitive etiology.

Study Hypothesis:Does probiotics(Saccharomyces boulardii improves daily bowel symptoms and quality of life in patients with diarrhea dominant irritable bowel syndrome?

Conditions

  • Irritable Bowel Syndrome

Interventions

DRUG

Saccharomyces boulardii

250mg, twice a day in sachets, for 8 weeks

DRUG

Methyl cellulose powder (low viscosity)

twice a day sachets for 10 weeks

Sponsors & Collaborators

  • Aga Khan University

    lead OTHER

Principal Investigators

  • Lubna Kamani, FCPS,MRCP · Aga Khan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Completion
2008-07-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00543478 on ClinicalTrials.gov